BA
54
5
DFS
64
2
UNP
52
7
PGR
65
2
IR
66
3
IPG
56
3
GT
62
6
MA
64
7
PFG
45
3
CA
38
6
TGT
22
2
JPM
69
2
CPB
30
6
A
43
2
VTR
47
-7
EQIX
64
2
ORCL
65
-2
F
58
11
CRM
67
2
BAC
53
3
BA
54
5
DFS
64
2
UNP
52
7
PGR
65
2
IR
66
3
IPG
56
3
GT
62
6
MA
64
7
PFG
45
3
CA
38
6
TGT
22
2
JPM
69
2
CPB
30
6
A
43
2
VTR
47
-7
EQIX
64
2
ORCL
65
-2
F
58
11
CRM
67
2
BAC
53
3
Financhill
Back

Xeris Biopharma Holdings Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
83

XERS
Xeris Biopharma Holdings

Last Price:
3.09
Seasonality Move:
5.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Xeris Biopharma Holdings Price Quote

$3.09

Xeris Biopharma Holdings Key Stats

Buy
83
Xeris Biopharma Holdings (XERS) is a Buy
Day range:
$3.02 - $3.10
52-week range:
$1.69 - $3.64
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.37
P/B ratio:
0%
Volume:
734.8K
Avg. volume:
1.6M
1-year change:
77.59%
Market cap:
$460.7M
Revenue:
$163.9M
EPS:
$-0.44

How Much Does Xeris Biopharma Holdings Make?

Is Xeris Biopharma Holdings Growing As A Company?

Xeris Biopharma Holdings Stock Price Performance

What Is Xeris Biopharma Holdings 52-Week High & Low?

Xeris Biopharma Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Xeris Biopharma Holdings?

Is Xeris Biopharma Holdings Cash Flow Positive?

  • What Is XERS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$31.5M
  • What Is Xeris Biopharma Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $34.5M
  • What Is Xeris Biopharma Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $9.7M

Xeris Biopharma Holdings Return On Invested Capital

  • Is Management Doing A Good Job?
    XERS return on invested capital is -31.15%
  • What Is Xeris Biopharma Holdings Return On Assets?
    ROA measures how assets are converting to revenues and is -19.24%
  • What Is XERS Return On Equity?
    ROE is a measure of profitability and is 0%

Xeris Biopharma Holdings Earnings Date & Stock Price

Xeris Biopharma Holdings Competitors

Xeris Biopharma Holdings Dividend Yield

Xeris Biopharma Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 21.05%
Revenue: 12.31% 5.51%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 4.77
Upside from Last Price: 54.26%

Major Shareholders

  • How many XERS shares are owned by institutional investors?
    83.1M XERS shares are owned by institutional investors
  • How many XERS shares are owned by insiders?
    13.4M XERS shares are owned by insiders